Role of Corticosteroids in COPD Management

Systemic Corticosteroids for Acute COPD Exacerbations

Systemic corticosteroids are strongly recommended for acute COPD exacerbations as they improve lung function, shorten recovery time, and reduce risk of treatment failure, according to the American College of Physicians 1
For ambulatory patients experiencing COPD exacerbations, a short course (≤14 days) of oral corticosteroids is recommended by the European Respiratory Society 2
The optimal regimen is 40mg prednisone daily for 5 days, with oral administration being equally effective as intravenous administration, as suggested by the American College of Physicians 1
Systemic corticosteroids improve oxygenation during acute exacerbations, contributing to faster clinical improvement and reduced risk of early relapse, according to the American College of Physicians 1
Patients with blood eosinophil counts ≥2% may show greater response to corticosteroids during exacerbations, as reported by the European Respiratory Society 2
Treatment should be initiated promptly to maximize benefits and limited to 5-7 days to minimize adverse effects, as recommended by the American College of Physicians 1

Short-term studies show no or marginal beneficial effects on symptoms, lung function, and hyperresponsiveness in stable COPD, according to the European Respiratory Society 3, 4
Only about 10% of patients with stable COPD will achieve a significant improvement in FEV₁ with corticosteroid therapy, as reported by the European Respiratory Society 3
ICS can reduce lymphocytic inflammation in COPD airways, with potentially more pronounced effects in patients with predominant lymphocytic airway inflammation, as suggested by the American Thoracic Society 5
Long-term oral corticosteroids should be administered only when there is a clear functional benefit (increase in postbronchodilator FEV₁ of 10% predicted and an absolute increase of at least 200 mL), as recommended by the European Respiratory Society 3, 4
ICS should not be continued long-term solely to prevent future exacerbations beyond the first 30 days after an acute exacerbation, according to the American College of Physicians 1

Well-known side-effects of systemic corticosteroids include obesity, muscle weakness, hypertension, psychiatric disorders, diabetes mellitus, osteoporosis, skin thinning, and bruising, as reported by the European Respiratory Society 3, 4
Short-term use of systemic corticosteroids carries risks including hyperglycemia, weight gain, and insomnia, according to the American College of Physicians 1
Inhaled corticosteroids have fewer systemic side-effects than oral corticosteroids, but high doses (>1,000 μg/day) may increase risks of osteoporosis and skin thinning, as suggested by the European Respiratory Society 3
Common side effects of inhaled corticosteroids include oral candidiasis and hoarseness, which can be minimized by using large-volume spacers and rinsing the mouth after use, as recommended by the European Respiratory Society 3, 4